nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP2C19—urine—polycystic ovary syndrome	0.0124	0.165	CbGeAlD
Ketobemidone—CYP2C9—urine—polycystic ovary syndrome	0.00959	0.128	CbGeAlD
Ketobemidone—CYP3A4—urine—polycystic ovary syndrome	0.00731	0.0974	CbGeAlD
Ketobemidone—UGT1A9—endocrine gland—polycystic ovary syndrome	0.00552	0.0735	CbGeAlD
Ketobemidone—OPRM1—endocrine gland—polycystic ovary syndrome	0.00298	0.0396	CbGeAlD
Ketobemidone—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00257	0.0342	CbGeAlD
Ketobemidone—CYP2C8—endometrium—polycystic ovary syndrome	0.00255	0.034	CbGeAlD
Ketobemidone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00231	0.0308	CbGeAlD
Ketobemidone—CYP2C19—vagina—polycystic ovary syndrome	0.00219	0.0292	CbGeAlD
Ketobemidone—PTGS1—endometrium—polycystic ovary syndrome	0.00207	0.0276	CbGeAlD
Ketobemidone—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00205	0.0273	CbGeAlD
Ketobemidone—CYP2C8—vagina—polycystic ovary syndrome	0.00191	0.0255	CbGeAlD
Ketobemidone—PTGS1—uterus—polycystic ovary syndrome	0.00191	0.0254	CbGeAlD
Ketobemidone—PTGS1—pituitary gland—polycystic ovary syndrome	0.00187	0.025	CbGeAlD
Ketobemidone—PTGS1—adipose tissue—polycystic ovary syndrome	0.00187	0.0249	CbGeAlD
Ketobemidone—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00185	0.0247	CbGeAlD
Ketobemidone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00179	0.0238	CbGeAlD
Ketobemidone—CYP2B6—vagina—polycystic ovary syndrome	0.00172	0.0229	CbGeAlD
Ketobemidone—PTGS1—adrenal gland—polycystic ovary syndrome	0.00167	0.0223	CbGeAlD
Ketobemidone—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00161	0.0214	CbGeAlD
Ketobemidone—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00159	0.0212	CbGeAlD
Ketobemidone—PTGS1—female gonad—polycystic ovary syndrome	0.00156	0.0208	CbGeAlD
Ketobemidone—PTGS1—vagina—polycystic ovary syndrome	0.00155	0.0207	CbGeAlD
Ketobemidone—PTGS1—endocrine gland—polycystic ovary syndrome	0.00145	0.0193	CbGeAlD
Ketobemidone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00121	0.0161	CbGeAlD
Ketobemidone—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000237	0.000256	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000237	0.000256	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000235	0.000255	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000235	0.000254	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000234	0.000253	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000233	0.000251	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000232	0.00025	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000231	0.00025	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00023	0.000249	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000229	0.000247	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000229	0.000247	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000227	0.000245	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000227	0.000245	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000226	0.000244	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000224	0.000242	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000219	0.000236	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000218	0.000235	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000218	0.000235	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000217	0.000235	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000217	0.000235	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000217	0.000234	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000217	0.000234	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000216	0.000233	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000215	0.000232	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000214	0.000231	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000213	0.00023	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	0.000212	0.000229	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.000212	0.000229	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00021	0.000227	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000209	0.000226	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000208	0.000225	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000208	0.000225	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000207	0.000224	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000207	0.000224	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000207	0.000224	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000207	0.000223	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000206	0.000223	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000206	0.000223	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000206	0.000222	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000204	0.000221	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000203	0.00022	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000203	0.000219	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000203	0.000219	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000202	0.000218	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000201	0.000217	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0002	0.000216	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000199	0.000216	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000198	0.000214	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000198	0.000214	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000197	0.000213	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000195	0.00021	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000194	0.000209	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000193	0.000209	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000192	0.000208	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000192	0.000207	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000191	0.000206	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000191	0.000206	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00019	0.000205	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000188	0.000204	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000186	0.000201	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000185	0.0002	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000185	0.000199	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000184	0.000199	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000184	0.000199	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000184	0.000199	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000183	0.000198	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000182	0.000196	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00018	0.000195	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.00018	0.000194	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	0.000179	0.000193	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000178	0.000193	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000177	0.000192	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000176	0.00019	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000176	0.00019	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000175	0.00019	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000174	0.000188	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	0.000173	0.000187	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000173	0.000187	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	0.000172	0.000186	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000171	0.000185	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00017	0.000184	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.00017	0.000184	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000168	0.000182	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000168	0.000181	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000167	0.000181	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	0.000166	0.000179	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000165	0.000178	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	0.000165	0.000178	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000164	0.000177	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000164	0.000177	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000164	0.000177	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000162	0.000175	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000161	0.000174	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000161	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.00016	0.000173	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00016	0.000173	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000159	0.000172	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000158	0.000171	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000158	0.000171	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000157	0.000169	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000156	0.000169	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000156	0.000169	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000156	0.000169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000155	0.000167	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000155	0.000167	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000153	0.000165	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000152	0.000165	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000152	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000152	0.000164	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000151	0.000164	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00015	0.000162	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000149	0.000162	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000146	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000146	0.000158	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	0.000145	0.000157	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000143	0.000154	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000141	0.000153	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000141	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.00014	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.00014	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000139	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000139	0.00015	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000138	0.00015	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000138	0.000149	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000137	0.000149	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000135	0.000146	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000135	0.000146	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000134	0.000145	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000134	0.000145	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000133	0.000144	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000132	0.000143	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TH—polycystic ovary syndrome	0.000132	0.000142	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000131	0.000142	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000131	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.00013	0.000141	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00013	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000129	0.000139	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000128	0.000139	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000128	0.000138	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000128	0.000138	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000127	0.000138	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.000138	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000125	0.000135	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000124	0.000135	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000124	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000124	0.000134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000123	0.000134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000123	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000123	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000123	0.000133	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000119	0.000129	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000119	0.000128	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	0.000118	0.000128	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000117	0.000127	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000117	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000117	0.000126	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	0.000116	0.000126	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—INS—polycystic ovary syndrome	0.000116	0.000125	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000115	0.000124	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000114	0.000123	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000114	0.000123	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000112	0.000121	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.000112	0.000121	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.000111	0.000121	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000111	0.00012	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000111	0.00012	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.000108	0.000117	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000108	0.000117	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000108	0.000117	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	0.000107	0.000116	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000106	0.000115	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000106	0.000114	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000105	0.000113	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000103	0.000111	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	0.000102	0.000111	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000102	0.00011	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TH—polycystic ovary syndrome	9.95e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.88e-05	0.000107	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	9.71e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	9.68e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.64e-05	0.000104	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	9.62e-05	0.000104	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	9.51e-05	0.000103	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—POMC—polycystic ovary syndrome	9.48e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	9.46e-05	0.000102	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.44e-05	0.000102	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—INS—polycystic ovary syndrome	9.43e-05	0.000102	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.42e-05	0.000102	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.15e-05	9.89e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.14e-05	9.89e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.12e-05	9.86e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	9.1e-05	9.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	9.1e-05	9.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TH—polycystic ovary syndrome	9.07e-05	9.81e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	9.05e-05	9.78e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	8.82e-05	9.54e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.69e-05	9.4e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	8.67e-05	9.37e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.4e-05	9.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	8.3e-05	8.97e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	8.28e-05	8.95e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	8.22e-05	8.88e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.13e-05	8.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	8.12e-05	8.78e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.07e-05	8.72e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.84e-05	8.47e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	7.74e-05	8.36e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	7.66e-05	8.28e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.53e-05	8.14e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.44e-05	8.04e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	7.41e-05	8.01e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	7.34e-05	7.93e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	7.33e-05	7.93e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	7.24e-05	7.82e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—INS—polycystic ovary syndrome	7.2e-05	7.78e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.07e-05	7.65e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	7.05e-05	7.63e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.02e-05	7.59e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	7e-05	7.57e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.91e-05	7.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	6.84e-05	7.39e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	6.69e-05	7.23e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	6.23e-05	6.74e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	6.21e-05	6.72e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	6.13e-05	6.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	6.09e-05	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.98e-05	6.47e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.98e-05	6.46e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.82e-05	6.29e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	5.58e-05	6.03e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.54e-05	5.99e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.47e-05	5.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.47e-05	5.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—INS—polycystic ovary syndrome	5.44e-05	5.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	5.06e-05	5.47e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.99e-05	5.39e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.96e-05	5.36e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	4.89e-05	5.29e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.88e-05	5.28e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.65e-05	5.03e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-05	4.77e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	4.13e-05	4.47e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-05	4.45e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.33e-05	3.6e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.29e-05	3.56e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.27e-05	3.54e-05	CbGpPWpGaD
